On Friday, Cathie Wooden-led Ark Make investments made a number of important trades. Essentially the most distinguished amongst these concerned the shopping for and promoting of shares in Intellia Therapeutics Inc. NTLA, Meta Platforms Inc. META, Veracyte Inc. VCYT, Symbotic Inc. SYM, Baidu Inc. BIDU, and UiPath Inc. PATH.
The NTLA Commerce: Ark Make investments’s ARK Innovation ETF ARKK fund bought 65,958 shares of Intellia Therapeutics. The shares have been purchased at a closing value of $8.31, making the full worth of the commerce roughly $548,136.78. This transfer comes amidst a 1.59% improve in NTLA’s inventory value.
The META Commerce: The ARK Autonomous Know-how & Robotics ETF ARKK fund bought 1,255 shares of Meta Platforms at a closing value of $547.27. The entire worth of this sale was roughly $686,324.85. This commerce was executed as META’s inventory value noticed a 2.65% improve.
The VCYT Commerce: Ark Make investments’s ARKK fund bought 66,135 shares of Veracyte. The shares have been bought at a closing value of $32.23, making the full worth of the commerce roughly $2,131,151.05. This sale was made as VCYT’s inventory value skilled a slight improve of 0.28%.
The SYM Commerce: ARK Subsequent Technology Web ETF ARKQ fund purchased 8,140 shares of Symbotic at a closing value of $21.93. The entire worth of this buy was roughly $178,410.20. This buy was made regardless of SYM’s inventory value seeing a lower of 0.59%.
The BIDU Commerce: The ARKQ fund additionally purchased 925 shares of Baidu at a closing value of $90.74. The entire worth of this buy was roughly $83,934.50. This commerce was executed as BIDU’s inventory value noticed a 1.39% improve.
The PATH Commerce: Ark’s ARKW fund bought 984 shares of UiPath at a closing value of $11.59. The entire worth of this sale was roughly $11,402.56. This sale was made as PATH’s inventory value skilled a 2.39% improve.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and revealed by Benzinga editors.
Picture courtesy: Shutterstock
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
